Pierre Arnaud

Galia Gestion SAS (Galia Gestion) is a regional French private equity firm which was created in 2002 to provide capital for small- to medium-sized businesses in the Aquitaine, Poitou-Charentes, Limousin and Midi-Pyrénées regions. Located in Bordeaux, Galia Gestion manages the Galia Investissements 1 and Expanso Investissements FCPRs, the Galia PME 1, 2, 3, 4, 5, 6, 7 and 8 FIPs, Galia Poitou Charentes FIP and Galia Venture, a venture capital firm, for institutional investors.

Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France.